Skip to main content

Find Clinical Trials

Home
Conditions
Malaria Vaccines

Clinical trial condition

Malaria Vaccines

Explore clinical trials studying Malaria Vaccines. Study availability and eligibility vary by location and protocol.

8 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Malaria Vaccines trial results

Recruiting

Infant Malaria Vaccine Schedule Optimization

NCT06879327

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: Institut de Recherche en Sciences de la Santé (IRSS) Bobo-Dioulasso, Burkina Faso

Groupe de Recherche Action en Santé (GRAS) Ouagadougou, Burkina Faso

View Trial Details

Recruiting

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

NCT07038837

Conditions: Infections, Malaria, Malaria Infection, +5 more
Locations: Medecin sans Frontières Moïssala, Mandoul Region, Chad

View Trial Details

Completed

A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

NCT03855995

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Navrongo, Ghana

GSK Investigational Site Kisumu, Kenya

GSK Investigational Site Kisumu, Kenya

View Trial Details

Completed

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

NCT02251704

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Nouna, Burkina Faso

GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Navrongo, Ghana

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

NCT02699099

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Kumasi, Ghana

View Trial Details

Completed

Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants

NCT00289185

Conditions: Coccidiosis, Infections, Malaria, +6 more
Locations: GSK Investigational Site Dar es Salaam, Tanzania

View Trial Details

Completed

Epidemiology Study of Malaria Transmission Intensity in Africa

NCT01190202

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Lambaréné, Gabon

GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Kumasi, Ghana

View Trial Details

Completed

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

NCT01345240

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations: GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Kumasi, Ghana

View Trial Details